IC
CELG

Inverness Counsel’s Celgene Corp CELG Stock Holding History

Inverness Counsel’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,700
Closed -$241K – 148
2018
Q1 		$241K Sell
2,700
-170,160
-98% -$16.3M 0.01% 126
2017
Q4 		$18M Sell
172,860
-57,910
-25% -$6.53M 1.13% 35
2017
Q3 		$33.7M Sell
230,770
-1,055
-0.5% -$144K 2.38% 8
2017
Q2 		$30.1M Buy
231,825
+15,911
+7% +$1.95M 2.09% 12
2017
Q1 		$27M Buy
215,914
+2,205
+1% +$264K 1.88% 16
2016
Q4 		$25.1M Buy
213,709
+8,018
+4% +$893K 1.9% 17
2016
Q3 		$21.5M Sell
205,691
-32,151
-14% -$3.48M 1.69% 26
2016
Q2 		$23.5M Buy
+237,842
New +$24.6M 1.82% 23

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Inverness Counsel's CELG Position: Q2 2018 in Review

Inverness Counsel sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 2,700 shares — an estimated $241K sold.

Inverness Counsel first reported a position in CELG in Q2 2016 and held it in 8 quarters. The position peaked at $33.7M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Inverness Counsel reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Inverness Counsel sold 2,700 Celgene Corp shares in Q2 2018, an estimated $241K.
  • Inverness Counsel first reported a position in Celgene Corp in Q2 2016 and held it in 8 quarters.
  • Inverness Counsel's Celgene Corp position peaked at $33.7M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Inverness Counsel's 13F filing for Q2 2018, filed 2 Aug 2018.